SOX2 and p53 Expression Control Converges in PI3K/AKT Signaling with Versatile Implications for Stemness and Cancer

被引:24
|
作者
Schaefer, Thorsten [1 ,2 ]
Steiner, Rebekah [2 ,3 ]
Lengerke, Claudia [1 ,2 ,4 ]
机构
[1] Univ Basel, Dept Biomed, Stem Cells & Hematopoiesis Lab, CH-4031 Basel, Switzerland
[2] Univ Hosp Basel, CH-4031 Basel, Switzerland
[3] Univ Basel, Dept Biomed, Immunol Lab, CH-4031 Basel, Switzerland
[4] Univ Hosp Tubingen, Internal Med 2, D-72076 Tubingen, Germany
关键词
SOX2; p53; PI3K; AKT signaling; stem cells; pluripotency; genome integrity; DNA maintenance; DNA damage response (DDR); transformation; cancer; DNA-DAMAGE RESPONSE; CELL SELF-RENEWAL; HEMATOPOIETIC STEM; MUTANT P53; TRANSCRIPTION FACTORS; SOMATIC-CELLS; TUMOR-SUPPRESSOR; STRESS DEFENSE; REPAIR DEFECTS; MOUSE;
D O I
10.3390/ijms21144902
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Stemness and reprogramming involve transcriptional master regulators that suppress cell differentiation while promoting self-renewal. A distinguished example thereof is SOX2, a high mobility group (HMG)-box transcription factor (TF), whose subcellular localization and turnover regulation in embryonic, induced-pluripotent, and cancer stem cells (ESCs, iPSCs, and CSCs, respectively) is mediated by the PI3K/AKT/SOX2 axis, a stem cell-specific branch of the PI3K/AKT signaling pathway. Further effector functions associated with PI3K/AKT induction include cell cycle progression, cellular (mass) growth, and the suppression of apoptosis. Apoptosis, however, is a central element of DNA damage response (DDR), where it provides a default mechanism for cell clearance when DNA integrity cannot be maintained. A key player in DDR is tumor suppressor p53, which accumulates upon DNA-damage and is counter-balanced by PI3K/AKT enforced turnover. Accordingly, stemness sustaining SOX2 expression and p53-dependent DDR mechanisms show molecular-functional overlap in PI3K/AKT signaling. This constellation proves challenging for stem cells whose genomic integrity is a functional imperative for normative ontogenesis. Unresolved mutations in stem and early progenitor cells may in fact provoke transformation and cancer development. Such mechanisms are also particularly relevant for iPSCs, where genetic changes imposed through somatic cell reprogramming may promote DNA damage. The current review aims to summarize the latest advances in the understanding of PI3K/AKT/SOX2-driven stemness and its intertwined relations to p53-signaling in DDR under conditions of pluripotency, reprogramming, and transformation.
引用
收藏
页码:1 / 21
页数:21
相关论文
共 50 条
  • [31] Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2
    Keysar, Stephen B.
    Le, Phuong N.
    Miller, Bettina
    Jackson, Brian C.
    Eagles, Justin R.
    Nieto, Cera
    Kim, Jihye
    Tang, Binwu
    Glogowska, Magdalena J.
    Morton, J. Jason
    Padilla-Just, Nuria
    Gomez, Karina
    Warnock, Emily
    Reisinger, Julie
    Arcaroli, John J.
    Messersmith, Wells A.
    Wakefield, Lalage M.
    Gao, Dexiang
    Tan, Aik-Choon
    Serracino, Hilary
    Vasiliou, Vasilis
    Roop, Dennis R.
    Wang, Xiao-Jing
    Jimeno, Antonio
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (01):
  • [32] Amplification of SOX4 promotes PI3K/Akt signaling in human breast cancer
    Mehta, Gaurav
    Gatza, Michael
    Angus, Steve
    Johnson, Gary
    CANCER RESEARCH, 2018, 78 (13)
  • [33] Targeting PI3K/Akt/mTOR signaling in cancer
    Porta, Camillo
    Paglino, Chiara
    Mosca, Alessandra
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [34] In vitro anticancer study of novel curcumin derivatives via targeting PI3K/Akt/p53 signaling pathway
    Zhou, Huixian
    Wu, Zhiwen
    Zhang, Yannan
    Yu, Zikai
    Nie, Zhengyang
    Fan, Jinbiao
    Zhu, Zuchang
    Chen, Fenglian
    Wang, Tao
    MOLECULAR DIVERSITY, 2025, 29 (01) : 73 - 86
  • [35] 3-Arylamino-quinoxaline-2-carboxamides inhibit the PI3K/Akt/mTOR signaling pathways to activate P53 and induce apoptosis
    Chen, Nan-Ying
    Lu, Ke
    Yuan, Jing-Mei
    Li, Xiao-Juan
    Gu, Zi-Yu
    Pan, Cheng-Xue
    Mo, Dong-Liang
    Su, Gui-Fa
    BIOORGANIC CHEMISTRY, 2021, 114
  • [36] Sox2 is involved in paclitaxel resistance of the prostate cancer cell line PC-3 via the PI3K/Akt pathway
    Li, Dong
    Zhao, Li-Nan
    Zheng, Xiu-Lan
    Lin, Ping
    Lin, Feng
    Li, Yue
    Zou, Hai-Feng
    Cui, Rong-Jun
    Chen, Hui
    Yu, Xiao-Guang
    MOLECULAR MEDICINE REPORTS, 2014, 10 (06) : 3169 - 3176
  • [37] Inhibition of MARK2 inhibits ovarian cancer cell proliferation by regulating PI3K/AKT/p53 axis
    Xiong, Weijie
    Xu, Hongyu
    Wang, Yuntao
    Wang, Ying
    He, Lang
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2023, 44 (05) : 132 - 139
  • [38] Kaempferol promotes the osteogenesis in rBMSCs via mediation of SOX2/ miR-124-3p/PI3K/Akt/mTOR axis
    Gan, Li
    Leng, Yu
    Min, Jun
    Luo, Xin-Ming
    Wang, Fen
    Zhao, Jing
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, 927
  • [39] Dual inhibition of PI3K/Akt signaling and the DNA damage checkpoint in p53-deficient cells with strong survival signaling - Implications for cancer therapy
    Skladanowski, Andrzej
    Bozko, Przemyslaw
    Sabisz, Michal
    Larsen, Annette K.
    CELL CYCLE, 2007, 6 (18) : 2268 - 2275
  • [40] Curcumin regulates proliferation, autophagy, and apoptosis in gastric cancer cells by affecting PI3K and P53 signaling
    Fu, Hongbing
    Wang, Changming
    Yang, Dejun
    Wei, Ziran
    Xu, Jiapeng
    Hu, Zunqi
    Zhang, Yu
    Wang, Weimin
    Yan, Ronglin
    Cai, Qingping
    JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (06) : 4634 - 4642